No effects of anti-motion sickness drugs on vestibular evoked myogenic potentials outcome parameters

Otology and Neurotology

Volumn 32, Issue 3, 2011, Pages 497-503

  Vanspauwen, Robby ^a,c   Weerts, Aurélie ^a   Hendrickx, Marilyn ^a   Buytaert, Kristof I ^a   Blaivie, Cathérine ^a,b   Jorens, Philippe G ^b   Van De Heyning, Paul H ^a,b   Wuyts, Floris L ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c SINT AUGUSTINUS HOSPITAL   (Belgium)

Author keywords

Pharmacological effects; Prospective randomized trial; Vestibular evoked myogenic potential

Indexed keywords

ANTIEMETIC AGENT; CINNARIZINE; DIMENHYDRINATE; HISTAMINE H1 RECEPTOR ANTAGONIST; MECLOZINE; PROMETHAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VESTIBULAR EVOKED MYOGENIC POTENTIAL;

ADULT; ANTIEMETICS; CINNARIZINE; DIMENHYDRINATE; DOUBLE-BLIND METHOD; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MECLIZINE; PROMETHAZINE; PROSPECTIVE STUDIES; VESTIBULAR EVOKED MYOGENIC POTENTIALS;

EID: 79953117900     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31820d94d0     Document Type: Article

References (80)

1. Colebatch JG, Halmagyi GM, Skuse NF. Myogenic potentials generated by a click-evoked vestibulocollic reflex. J Neurol Neurosurg Psychiatry 1994;57:190-7. (Pubitemid 24050459)
2. Murofushi T, Curthoys IS, Gilchrist DP. Response of guinea pig vestibular nucleus neurons to clicks. Exp Brain Res 1996;111:149-52. (Pubitemid 26300818)
3. Uchino Y, Sato H, Sasaki M, et al. Sacculocollic reflex arcs in cats. J Neurophysiol 1997;77:3003-12. (Pubitemid 27290871)
4. Wilson VJ, Boyle R, Fukushima K, et al. The vestibulocollic reflex. J Vestib Res 1995;5:147-70.
5. Shellenberger MK, Groves L, Shah J, Novack GD. A controlled pharmacokinetic evaluation of tizanidine and baclofen at steady state. Drug Metab Dispos 1999;27:201-4. (Pubitemid 29072072)
6. Hernandez-Trujillo VP, Lieberman P. Antihistamines. In: Lieberman P, Anderson JA, eds. Allergic diseases. Diagnosis and treatment, 3rd ed. Totowa, NJ: Humana Press, Inc., 2007:319-34.
7. Morrison PJ, Bradbrook ID, Rogers HJ. Plasma cinnarizine levels resulting from oral administration as capsule or tablet formulation investigated by gas-liquid chromatography. Br J Clin Pharmacol 1979;7:349-52. (Pubitemid 9140086)
8. Scavone JM, Luna BG, Harmatz JS, von Moltke L, Greenblatt DJ. Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration. Biopharm Drug Dispos 1990;11:185-9. (Pubitemid 20271426)
9. Taylor G, Houston JB, Shaffer J, Mawer G. Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. Br J Clin Pharmacol 1983;15:287-93. (Pubitemid 13137452)
10. De La Torre R, Farré M, Navarro M, Pacifici R, Zuccaro P, Pichini S. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet 2004;43:157-85. (Pubitemid 38294379)
11. Merritt JL. Management of spasticity in spinal cord injury. Mayo Clin Proc 1981;56:614-22. (Pubitemid 12239014)
12. Arab SF, Düwel P, Jüngling E, Westhofen M, Lückhoff A. Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol 2004;369:570-5. (Pubitemid 38823989)
13. Düwel P, Haasler T, Jüngling E, Duong TA, Westhofen M, Lückhoff A. Effects of cinnarizine on calcium and pressuredependent potassium currents in guinea pig vestibular hair cells. Naunyn Schmiedebergs Arch Pharmacol 2005;371:441-8. (Pubitemid 41218963)
14. Shupak A, Doweck I, Gordon CR, Spitzer O. Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study. Clin Pharmacol Ther 1994;55:670-80. (Pubitemid 24212268)
15. Emanuel MB. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 1979;30:454-69. (Pubitemid 9244039)
16. Lucertini M, Mirante N, Casagrande M, Trivelloni P, Lugli V. The effect of cinnarizine and cocculus indicus on simulator sickness. Physiol Behav 2007;91:180-90. (Pubitemid 46621126)
17. Nicholson AN, Stone BM, Turner C, Mills SL. Central effects of cinnarizine: restricted use in aircrew. Aviat Space Environ Med 2002;73:570-4. (Pubitemid 34547511)
18. Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J Psychopharmacol 2001;15:167-72. (Pubitemid 32808249)
19. Brandt T, Dichgans J, Wagner W. Drug effectiveness on experimental optokinetic and vestibular motion sickness. Aerosp Med 1974;45:1291-7.
20. Holtmann S, Clarke AH, Scherer H, Höhn M. The anti-motion sickness mechanism of ginger. A comparative study with placebo and dimenhydrinate. Acta Otolaryngol 1989;108:168-74. (Pubitemid 19240253)
21. Pyykkö I, Schalén L, Jäntti V, Magnusson M. A reduction of vestibulovisual integration during transdermally administered scopolamine and dimenhydrinate. A presentation of gain control theory in motion sickness. Acta Otolaryngol Suppl 1984;406:167-73. (Pubitemid 14082022)
22. Pytel J, Nagy G, Tóth A, Spellenberg S, Schwarz M, Répassy G. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active-and placebo-controlled, parallelgroup, outpatient study. Clin Ther 2007;29:84-98. (Pubitemid 46414031)
23. Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a doubleblind, randomized, parallel-group clinical study. Clin Ther 2004;26:866-77. (Pubitemid 38943035)
24. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985;17:107-16. (Pubitemid 15170430)
25. Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline- insensitive GABA B sites in rat brain. Nature 1981;290:149-52. (Pubitemid 11149692)
26. Kushiro K, Dai M, Kunin M, Yakushin SB, Cohen B, Raphan T. Compensatory and orienting eye movements induced by off-vertical axis rotation (OVAR) in monkeys. J Neurophysiol 2002;88:2445-62. (Pubitemid 35346049)
27. Magnusson AK, Eriksson B, Tham R. Effects of the GABA agonists baclofen and THIP on long-term compensation in hemilabyrinthectomised rats. Brain Res 1998;795:307-11. (Pubitemid 28337845)
28. Dieterich M, Straube A, Brandt T, Paulus W, Büttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 1991;54:627-32.
29. Halmagyi GM, Rudge P, Gresty MA, Leigh RJ, Zee DS. Treatment of periodic alternating nystagmus. Ann Neurol 1980;8:609-11. (Pubitemid 11213506)
30. Tilikete C, Vighetto A, Trouillas P, Honnorat J. Anti-GAD antibodies and periodic alternating nystagmus. Arch Neurol 2005;62:1300-3. (Pubitemid 41168360)
31. Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibulo-ocular reflex by the nodulus and uvula. Science 1985;228:199-202. (Pubitemid 15117277)
32. Cohen B, Helwig D, Raphan T. Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey. J Physiol 1987;393:703-25. (Pubitemid 18046972)
33. Dai M, Raphan T, Cohen B. Effects of baclofen on the angular vestibulo-ocular reflex. Exp Brain Res 2006;171:262-71.
34. Magnusson AK, Ulfendahl M, Tham R. Early compensation of vestibulo-oculomotor symptoms after unilateral vestibular loss in rats is related to GABA (B) receptor function. Neuroscience 2002;111:625-34. (Pubitemid 34521900)
35. Yamanaka T, Him A, Cameron SA, Dutia MB. Rapid compensatory changes in GABA receptor efficacy in rat vestibular neurones after unilateral labyrinthectomy. J Physiol 2000;523:413-24. (Pubitemid 30137649)
36. Davis JR, Jennings RT, Beck BG. Comparison of treatment strategies for Space Motion Sickness. Microgravity Q 1992;2:173-7.
37. Jennings RT. Managing space motion sickness. J Vestib Res 1998;8:67-70. (Pubitemid 28078587)
38. Lackner JR, Graybiel A. Use of promethazine to hasten adaptation to provocative motion. J Clin Pharmacol 1994;34:644-8. (Pubitemid 24187984)
39. Wood CD, Stewart JJ, Wood MJ, Mims M. Effectiveness and duration of intramuscular antimotion sickness medications. J Clin Pharmacol 1992;32:1008-12.
40. Wood CD, Manno JE, Manno BR, Redetzki HM, Wood MJ, Mims ME. Evaluation of antimotion sickness drug side effects on performance. Aviat Space Environ Med 1985;56:310-6. (Pubitemid 15249474)
41. Schroeder DJ, Collins WE, Elam GW. Effects of some motion sickness suppressants on static and dynamic tracking performance. Aviat Space Environ Med 1985;56:344-50. (Pubitemid 15249480)
42. Wood CD, Manno JE, Manno BR, Redetzki HM, Wood M, Vekovius WA. Side effects of antimotion sickness drugs. Aviat Space Environ Med 1984;55:113-6. (Pubitemid 14155536)
43. Wood CD, Manno JE, Wood MJ, Manno BR, Redetzki HM. Mechanisms of antimotion sickness drugs. Aviat Space Environ Med 1987;58: A262-5. (Pubitemid 18040422)
44. Putcha L, Berens KL, Marshburn TH, Ortega HJ, Billica RD. Pharmaceutical use by U. S. astronauts on space shuttle missions. Aviat Space Environ Med 1999;70:705-8. (Pubitemid 29302912)
45. Cohen B, De Jong JM. Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study. Arch Neurol 1972;27:129-35.
46. Reason JT, Brand JJ. Preventive measures. In Reason JT, Brand JJ, eds. Motion Sickness. London, UK: Academic Press, Inc., 1975:211-33.
47. Wood CD. Pharmacological countermeasures against motion sickness. In: Crampton GH, editor. Motion and space sickness. Boca Raton, FL: CRC Press, Inc., 1990:343-51.
48. Wuyts FL, Pauwels G, Vanspauwen R, Van de Heyning PH: Pharmaceutical Countermeasures for Space Motion Sickness and their opposite effect on the otolith and canal function in humans. Presented at 75th conference of the Aerospace Medical Association (ASMA), Alaska, May 2004.
49. Furuya N, Yabe T, Koizumi T. Neurotransmitters regulating vestibular commissural inhibition in the cat. Acta Otolaryngol Suppl 1991;481:205-8.
50. Furuya N, Yabe T, Koizumi T. Neurotransmitters in the vestibular commissural system of the cat. Ann N Y Acad Sci 1992;656:594-601.
51. Holstein GR, Martinelli GP, Cohen B. L-baclofen-sensitive GABAB binding sites in the medial vestibular nucleus localized by immunocytochemistry. Brain Res 1992;581:175-80.
52. Zanni M, Giardino L, Toschi L, Galetti G, Calzà L. Distribution of neurotransmitters, neuropeptides, and receptors in the vestibular nuclei complex of the rat: an immunocytochemical, in situ hybridization and quantitative receptor autoradiographic study. Brain Res Bull 1995;36:443-52.
53. Dutia MB, Johnston AR, McQueen DS. Tonic activity of rat medial vestibular nucleus neurones in vitro and its inhibition by GABA. Exp Brain Res 1992;88:466-72.
54. Him A, Johnston AR, Yau JL, Seckl J, Dutia MB. Tonic activity and GABA responsiveness of medial vestibular nucleus neurons in aged rats. Neuroreport 2001;12:3965-8. (Pubitemid 33152434)
55. Smith PF, Darlington CL, Hubbard JI. Evidence for inhibitory amino acid receptors on guinea pig medial vestibular nucleus neurons in vitro. Neurosci Lett 1991;121:244-6.
56. Sun Y, Godfrey DA, Rubin AM. Plasticity of gamma-aminobutyrate receptors in the medial vestibular nucleus of rat after inferior cerebellar peduncle transection. J Vestib Res 2002;12:1-14. (Pubitemid 36791615)
57. Vibert N, Serafin M, Crambes O, Vidal PP, Mühlethaler M. Dopaminergic agonists have both presynaptic and postsynaptic effects on the guinea-pig's medial vestibular nucleus neurons. Eur J Neurosci 1995;7:555-62.
58. Vibert N, Serafin M, Vidal PP, Mühlethaler M. Direct and indirect effects of muscimol on medial vestibular nucleus neurones in guinea-pig brainstem slices. Exp Brain Res 1995;104:351-6.
59. Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience 1988;26:553-600.
60. Burke RE, Fahn S. Choline acetyltransferase activity of the principal vestibular nuclei of rat, studied by micropunch technique. Brain Res 1985;328:196-9. (Pubitemid 15146784)
61. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]-nicotine, and [125I]-alpha-bungarotoxin. J Neurosci 1985;5:1307-15. (Pubitemid 15098442)
62. Rotter A, Birdsall NJ, Field PM, Raisman G. Muscarinic receptors in the central nervous system of the rat. II. Distribution of binding of [3H]propylbenzilylcholine mustard in the midbrain and hindbrain. Brain Res 1979;180:167-83. (Pubitemid 10194717)
63. Schwartz RD. Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labeled with [3H]acetylcholine in rat brain. Life Sci 1986;38:2111-9. (Pubitemid 16122644)
64. Wamsley JK, Lewis MS, Young WS 3rd, Kuhar MJ. Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J Neurosci 1981;1:176-91. (Pubitemid 11028322)
65. Sun Y, Waller HJ, Godfrey DA, Rubin AM. Spontaneous activity in rat vestibular nuclei in brain slices and effects of acetylcholine agonists and antagonists. Brain Res 2002;934:58-68. (Pubitemid 34286568)
66. Swanson LW, Simmons DM, Whiting PJ, Lindstrom J. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci 1987;7:3334-42.
67. Kirsten EB, Sharma JN. Characteristics and response differences to iontophoretically applied norepinephrine, D-amphetamine and acetylcholine on neurons in the medial and lateral vestibular nuclei of the cat. Brain Res 1976;112:77-90.
68. Ono S, Kushiro K, Zakir M, Meng H, Sato H, Uchino Y. Properties of utricular and saccular nerve-activated vestibulocerebellar neurons in cats. Exp Brain Res 2000;134:1-8.
69. Sato H, Ohkawa T, Uchino Y, Wilson VJ. Excitatory connections between neurons of the central cervical nucleus and vestibular neurons in the cat. Exp Brain Res 1997;115:381-6. (Pubitemid 27296436)
70. Newlands SD, Vrabec JT, Purcell IM, Stewart CM, Zimmerman BE, Perachio AA. Central projections of the saccular and utricular nerves in macaques. J Comp Neurol 2003;466:31-47. (Pubitemid 37193685)
71. Cazals Y, Erre JP, Aurousseau C. Eighth nerve auditory evoked responses recorded at the base of the vestibular nucleus in the guinea pig. Hear Res 1987;31:93-7.
72. Didier A, Cazals Y, Aurousseau C. Brainstem connections of the anterior and posterior parts of the saccule in the guinea pig. Acta Otolaryngol 1987;104:385-91. (Pubitemid 18018480)
73. Gstoettner W, Burian M, Cartellieri M. Central projections from singular parts of the vestibular labyrinth in the guinea pig. Acta Otolaryngol 1992;112:486-95.
74. Dickman JD. Vestibular afferent projections to the brain stem in pigeons. Ann N Y Acad Sci 1996;781:611-3. (Pubitemid 26273115)
75. Newlands SD, Perachio AA. Central projections of the vestibular nerve: a review and single fiber study in the Mongolian gerbil. Brain Res Bull 2003;60:475-95. (Pubitemid 36638313)
76. Doweck I, Gordon CR, Spitzer O, Melamed Y, Shupak A. The vestibulo-ocular reflex (VOR) under the influence of cinnarizine. J Vestib Res 1994;4:215-20. (Pubitemid 24155163)
77. Pyykkö I, Padoan S, Schalén L, Lyttkens L, Magnusson M, Henriksson NG. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus. Aviat Space Environ Med 1985;56:777-82. (Pubitemid 15047744)
78. Novotn] M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 2002;8:115-23. (Pubitemid 36008810)
79. Dai M, Kaufmann H, Raphan T, Cohen B. Promethazine affects optokinetic but not vestibular responses in monkeys. Aviat Space Environ Med 2000;71:1003-12.
80. Vanspauwen R, Wuyts FL, Van de Heyning PH. Vestibular evoked myogenic potentials: test-retest reliability and normative values obtained with a feedback method for the sternocleidomastoid muscle contraction. J Vestib Res 2009;19:127-35.